SCHEMBL9826643

SCHEMBL9826643

COc1ccc(CCCCc2ccc(C(N)=O)cc2)cc1OC

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 2/20 0.61
▸ PDE4B Q07343 2/20 0.61
▸ PDE4C Q08493 2/20 0.61
▸ PDE4D Q08499 2/20 0.61
▸ CYP19A1 P11511 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.56
▸ ATM Q13315 1/20 0.56
▸ MAPK1 P28482 1/20 0.55
▸ NPC1 O15118 1/20 0.52
▸ LMNA P02545 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ PLAAT3 P53816 1/20 0.52
▸ PLAAT5 Q96KN8 1/20 0.52
▸ PLAAT2 Q9NWW9 1/20 0.52
▸ PLAAT4 Q9UL19 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10411341 0.97 PDE4A (0.57) PDE4APDE4BPDE4CPDE4DCYP19A1
SCHEMBL9826497 0.94 CYP19A1 (0.65) PDE4APDE4BPDE4CPDE4DCYP19A1
SCHEMBL2221405 0.84 KDM4E (0.59) CYP19A1KDM4EATMPLAAT3PLAAT5
SCHEMBL30869991 0.83 ATM (0.70) CYP19A1KDM4EATMMAPT
SCHEMBL10343404 0.83 ATM (0.70) CYP19A1KDM4EATMMAPT
SCHEMBL5192275 0.83 KDM4E (0.57) CYP19A1KDM4EATMPLAAT3PLAAT5
SCHEMBL2224074 0.82 ATM (0.61) CYP19A1KDM4EATMPLAAT3PLAAT5
SCHEMBL23913120 0.81 ATM (0.68) CYP19A1KDM4EATMMAPT
SCHEMBL31556190 0.81 ATM (0.68) CYP19A1KDM4EATMMAPT
SCHEMBL31556187 0.81 ATM (0.68) CYP19A1KDM4EATMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0221346-B1 (N-SUBSTITUTED-2-HYDROXY) BENZAMIDES AND N-SUBSTITUTED-2-HYDROXY-ALPHA-OXO-BENZENEACETAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF HAVING ACTIVITY AS MODULATORS OF THE ARACHIDONIC ACID CASCADE WARNER-LAMBERT COMPANY (US) 1991-01-30 — — EP disclosed
US-4939133-A N-substituted-2-hydroxy-α-oxo-benzeneacetamides and pharmaceutical compositions having activity as modulators of the arachidonic acid cascade WARNER-LAMBERT COMPANY (US) 1990-07-03 — — US disclosed
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US disclosed
US-4868195-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868200-A LEUKOTRIENES, LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868205-A ANTIALLERGENS, ANTIINFLAMMATORY, CARDIOVASCULAR DISORDERS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868199-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4761424-A Enolamides, pharmaceutical compositions and methods for treating inflammation WARNER-LAMBERT COMPANY (US) 1988-08-02 — — US disclosed
EP-0221346-A1 (N-substituted-2-hydroxy) benzamides and N-substituted-2-hydroxy-alpha-oxo-benzeneacetamides and pharmaceutical compositions thereof having activity as modulators of the arachidonic acid cascade WARNER-LAMBERT COMPANY (US) 1987-05-13 — — EP disclosed
EP-0221345-A1 Novel enolamides, process for their manufacture and pharmaceutical compositions thereof with an activity as modulators of the arachidonic acid cascade WARNER-LAMBERT COMPANY (US) 1987-05-13 — — EP disclosed
Send feedback